Group K Diagnostics (GKD) and Health Network Laboratories (HNL) announce a collaboration to bring improved clinical experiences to patients and caregivers alike.
The partners plan to validate the accuracy, effectiveness, and clinical implications of Group K's MultiNostic liver function test, which is pending FDA clearance.Read More
GKD will be in attendance for this year’s AACC Conference in Anaheim, CA in early August.Read More
It's been a busy few months here at Group K Diagnostics, let us fill you in...Read More
GKD has partnered with the CDC to begin working on a point-of-care Zika Virus Test.Read More